Home LiteratureArticle Details
PMID: 12692245 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Functional surfaces of the human immunodeficiency virus type 1 capsid protein.

Journal of virology ·Vol. 77 ·No. 9 ·2003-05-00 ·Pages 5439-50

von Schwedler UK, Stray KM, Garrus JE, Sundquist WI

Abstract

The human immunodeficiency virus type 1 initially assembles and buds as an immature particle that is organized by the viral Gag polyprotein. Gag is then proteolyzed to produce the smaller capsid protein CA, which forms the central conical capsid that surrounds the RNA genome in the mature, infectious virus. To define CA surfaces that function at different stages of the viral life cycle, a total of 48 different alanine-scanning surface mutations in CA were tested for their effects on Gag protein expression, processing, particle production and morphology, capsid assembly, and infectivity. The 27 detrimental mutations fall into three classes: 13 mutations significantly diminished or altered particle production, 9 mutations failed to assemble normal capsids, and 5 mutations supported normal viral assembly but were nevertheless reduced more than 20-fold in infectivity. The locations of the assembly-defective mutations implicate three different CA surfaces in immature particle assembly: one surface encompasses helices 4 to 6 in the CA N-terminal domain (NTD), a second surrounds the crystallographically defined CA dimer interface in the C-terminal domain (CTD), and a third surrounds the loop preceding helix 8 at the base of the CTD. Mature capsid formation required a distinct surface encompassing helices 1 to 3 in the NTD, in good agreement with a recent structural model for the viral capsid. Finally, the identification of replication-defective mutants with normal viral assembly phenotypes indicates that CA also performs important nonstructural functions at early stages of the viral life cycle.

MeSH Terms
Amino Acid Sequence Capsid/metabolism Capsid Proteins/chemistry,genetics,metabolism Cell Line Gene Products, gag/chemistry,metabolism HIV-1/genetics,metabolism,pathogenicity HeLa Cells Humans Microscopy, Electron Models, Molecular Molecular Sequence Data Mutagenesis, Site-Directed Virion/genetics,metabolism,ultrastructure Virus Assembly
Chemicals
Capsid Proteins Gene Products, gag
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
von Schwedler Uta K
Department of Biochemistry, University of Utah, Salt Lake City 84132, USA.
Stray Kirsten M
Garrus Jennifer E
Sundquist Wesley I
References (100)
100 references, click to expand
  1. Molecular recognition in the HIV-1 capsid/cyclophilin A complex.
    J Mol Biol. 1997 Jun 27;269(5):780-95 PMID: 9223641
  2. Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly.
    Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):3099-104 PMID: 8610175
  3. Mutations in the Ty3 major homology region affect multiple steps in Ty3 retrotransposition.
    J Virol. 1996 Jun;70(6):3440-8 PMID: 8648676
  4. Structure of the amino-terminal core domain of the HIV-1 capsid protein.
    Science. 1996 Jul 12;273(5272):231-5 PMID: 8662505
  5. Structural analysis of human immunodeficiency virus type 1 Gag protein interactions, using cysteine-specific reagents.
    J Virol. 1996 Aug;70(8):5106-14 PMID: 8764018
  6. Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1.
    J Virol. 2000 Feb;74(3):1168-77 PMID: 10627527
  7. Solution structure and dynamics of the Rous sarcoma virus capsid protein and comparison with capsid proteins of other retroviruses.
    J Mol Biol. 2000 Feb 18;296(2):633-49 PMID: 10669613
  8. Contribution of surface salt bridges to protein stability.
    Biochemistry. 2000 Feb 15;39(6):1251-5 PMID: 10684603
  9. Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication.
    Virology. 2000 Mar 15;268(2):294-307 PMID: 10704338
  10. Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA.
    J Virol. 2000 Apr;74(7):3046-57 PMID: 10708419
  11. Rescue of multiple viral functions by a second-site suppressor of a human immunodeficiency virus type 1 nucleocapsid mutation.
    J Virol. 2000 May;74(9):4273-83 PMID: 10756042
  12. Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding.
    J Virol. 2000 Jun;74(11):5142-50 PMID: 10799589
  13. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain.
    J Virol. 2000 Jun;74(12):5395-402 PMID: 10823843
  14. Structure and self-association of the Rous sarcoma virus capsid protein.
    Structure. 2000 Jun 15;8(6):617-28 PMID: 10873863
  15. Image reconstructions of helical assemblies of the HIV-1 CA protein.
    Nature. 2000 Sep 21;407(6802):409-13 PMID: 11014200
  16. Viral DNA synthesis defects in assembly-competent Rous sarcoma virus CA mutants.
    J Virol. 2001 Jan;75(1):242-50 PMID: 11119594
  17. Organization of immature human immunodeficiency virus type 1.
    J Virol. 2001 Jan;75(2):759-71 PMID: 11134289
  18. Contributions of engineered surface salt bridges to the stability of T4 lysozyme determined by directed mutagenesis.
    Biochemistry. 1991 Jul 23;30(29):7142-53 PMID: 1854726
  19. Form, function, and use of retroviral gag proteins.
    AIDS. 1991 Jun;5(6):639-54 PMID: 1883539
  20. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene.
    J Virol. 1992 Apr;66(4):2232-9 PMID: 1548759
  21. Characterization of HIV-1 p24 self-association using analytical affinity chromatography.
    Proteins. 1992 Apr;13(2):112-9 PMID: 1620693
  22. Assembly of recombinant human immunodeficiency virus type 1 capsid protein in vitro.
    J Virol. 1992 Aug;66(8):4874-83 PMID: 1629958
  23. Mutational analysis of the major homology region of Mason-Pfizer monkey virus by use of saturation mutagenesis.
    J Virol. 1992 Dec;66(12):7021-32 PMID: 1279197
  24. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells.
    J Virol. 1993 Aug;67(8):4945-55 PMID: 8331734
  25. A large deletion in the matrix domain of the human immunodeficiency virus gag gene redirects virus particle assembly from the plasma membrane to the endoplasmic reticulum.
    J Virol. 1993 Aug;67(8):4972-80 PMID: 8331736
  26. Production of high-titer helper-free retroviruses by transient transfection.
    Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8392-6 PMID: 7690960
  27. Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis.
    J Virol. 1994 Aug;68(8):4927-36 PMID: 8035491
  28. HIV-1 reverse transcription. A termination step at the center of the genome.
    J Mol Biol. 1994 Sep 2;241(5):651-62 PMID: 7520946
  29. Functional domains of the capsid protein of human immunodeficiency virus type 1.
    J Virol. 1994 Dec;68(12):8180-7 PMID: 7966609
  30. Specific incorporation of cyclophilin A into HIV-1 virions.
    Nature. 1994 Nov 24;372(6504):359-62 PMID: 7969494
  31. Functional association of cyclophilin A with HIV-1 virions.
    Nature. 1994 Nov 24;372(6504):363-5 PMID: 7969495
  32. Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity.
    J Virol. 1995 Feb;69(2):642-50 PMID: 7815527
  33. A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1.
    AIDS Res Hum Retroviruses. 1994 Dec;10(12):1651-8 PMID: 7888224
  34. The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity.
    J Virol. 1995 Jun;69(6):3407-19 PMID: 7745687
  35. Characterization of Rous sarcoma virus Gag particles assembled in vitro.
    J Virol. 2001 Mar;75(6):2753-64 PMID: 11222698
  36. Structural analysis of the N-terminal domain of the human T-cell leukemia virus capsid protein.
    J Mol Biol. 2001 Mar 2;306(4):783-97 PMID: 11243788
  37. Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism.
    J Virol. 1997 Sep;71(9):6582-92 PMID: 9261380
  38. Mutations in the N-terminal domain of human immunodeficiency virus type 1 nucleocapsid protein affect virion core structure and proviral DNA synthesis.
    J Virol. 1997 Sep;71(9):6973-81 PMID: 9261426
  39. Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein.
    Science. 1997 Oct 31;278(5339):849-53 PMID: 9346481
  40. Cryo-electron microscopy reveals ordered domains in the immature HIV-1 particle.
    Curr Biol. 1997 Oct 1;7(10):729-38 PMID: 9368755
  41. In vitro assembly properties of purified bacterially expressed capsid proteins of human immunodeficiency virus.
    Eur J Biochem. 1997 Oct 15;249(2):592-600 PMID: 9370371
  42. Analysis of the assembly function of the human immunodeficiency virus type 1 gag protein nucleocapsid domain.
    J Virol. 1998 Mar;72(3):1782-9 PMID: 9499028
  43. A putative alpha-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly.
    J Virol. 1998 Mar;72(3):2072-8 PMID: 9499062
  44. Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly.
    EMBO J. 1998 Mar 16;17(6):1555-68 PMID: 9501077
  45. Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites.
    J Virol. 1998 Apr;72(4):2846-54 PMID: 9525604
  46. Cryoelectron microscopic examination of human immunodeficiency virus type 1 virions with mutations in the cyclophilin A binding loop.
    J Virol. 1998 May;72(5):4403-7 PMID: 9557731
  47. Efficient HIV-1 replication can occur in the absence of the viral matrix protein.
    EMBO J. 1998 May 1;17(9):2699-708 PMID: 9564051
  48. N-Terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles.
    J Virol. 1998 Jun;72(6):4798-810 PMID: 9573245
  49. Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms.
    Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7299-304 PMID: 9636143
  50. The C-terminal half of the human immunodeficiency virus type 1 Gag precursor is sufficient for efficient particle assembly.
    J Virol. 1998 Nov;72(11):9313-7 PMID: 9765481
  51. Molecular events in the assembly of retrovirus particles.
    Adv Exp Med Biol. 1998;440:329-39 PMID: 9782300
  52. HIV-1 gag proteins: diverse functions in the virus life cycle.
    Virology. 1998 Nov 10;251(1):1-15 PMID: 9813197
  53. The role of nucleocapsid of HIV-1 in virus assembly.
    Virology. 1998 Nov 10;251(1):141-57 PMID: 9813210
  54. Structural biology of HIV.
    J Mol Biol. 1999 Jan 8;285(1):1-32 PMID: 9878383
  55. Assembly and analysis of conical models for the HIV-1 core.
    Science. 1999 Jan 1;283(5398):80-3 PMID: 9872746
  56. Model for lentivirus capsid core assembly based on crystal dimers of EIAV p26.
    J Mol Biol. 1999 Feb 12;286(1):83-93 PMID: 9931251
  57. Head-to-tail dimers and interdomain flexibility revealed by the crystal structure of HIV-1 capsid protein (p24) complexed with a monoclonal antibody Fab.
    EMBO J. 1999 Mar 1;18(5):1124-36 PMID: 10064580
  58. Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of gag membrane targeting.
    J Virol. 1999 Apr;73(4):2604-12 PMID: 10074105
  59. Structures of the HIV-1 capsid protein dimerization domain at 2.6 A resolution.
    Acta Crystallogr D Biol Crystallogr. 1999 Jan;55(Pt 1):85-92 PMID: 10089398
  60. Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus.
    J Virol. 1999 May;73(5):4136-44 PMID: 10196310
  61. Cyclophilin A incorporation is not required for human immunodeficiency virus type 1 particle maturation and does not destabilize the mature capsid.
    Virology. 1999 Apr 25;257(1):261-74 PMID: 10208939
  62. Identification of three major phosphorylation sites within HIV-1 capsid. Role of phosphorylation during the early steps of infection.
    J Biol Chem. 1999 Jul 2;274(27):19434-40 PMID: 10383459
  63. Solution structure of the capsid protein from the human T-cell leukemia virus type-I.
    J Mol Biol. 1999 Aug 13;291(2):491-505 PMID: 10438634
  64. Human immunodeficiency virus type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein.
    J Virol. 1999 Oct;73(10):8527-40 PMID: 10482606
  65. Association of Nef with the human immunodeficiency virus type 1 core.
    J Virol. 1999 Oct;73(10):8824-30 PMID: 10482638
  66. Second-site suppressors of Rous sarcoma virus Ca mutations: evidence for interdomain interactions.
    J Virol. 2001 Aug;75(15):6850-6 PMID: 11435564
  67. Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells.
    J Virol. 2001 Oct;75(19):9357-66 PMID: 11533199
  68. HIV-1 and Ebola virus: the getaway driver nabbed.
    Nat Med. 2001 Dec;7(12):1278-80 PMID: 11726960
  69. Resistance is futile: assimilation of cellular machinery by HIV-1.
    Immunity. 2001 Nov;15(5):687-90 PMID: 11728331
  70. The HIV-1 assembly machine.
    AIDS. 2001;15 Suppl 5:S13-20 PMID: 11816161
  71. Identification of a minimal HIV-1 gag domain sufficient for self-association.
    Virology. 2002 Mar 1;294(1):141-50 PMID: 11886273
  72. Molecular organization of Mason-Pfizer monkey virus capsids assembled from Gag polyprotein in Escherichia coli.
    J Virol. 2002 May;76(9):4321-30 PMID: 11932398
  73. Viral late domains.
    J Virol. 2002 May;76(10):4679-87 PMID: 11967285
  74. Tsg101: HIV-1's ticket to ride.
    Trends Microbiol. 2002 May;10(5):203-5 PMID: 11973141
  75. Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication.
    J Virol. 2002 Jun;76(11):5667-77 PMID: 11991995
  76. Nucleic acid-independent retrovirus assembly can be driven by dimerization.
    J Virol. 2002 Nov;76(22):11177-85 PMID: 12388677
  77. Characterization of a putative alpha-helix across the capsid-SP1 boundary that is critical for the multimerization of human immunodeficiency virus type 1 gag.
    J Virol. 2002 Nov;76(22):11729-37 PMID: 12388733
  78. Retrovirus capsid protein assembly arrangements.
    J Mol Biol. 2003 Jan 3;325(1):225-37 PMID: 12473464
  79. Identification of novel interactions in HIV-1 capsid protein assembly by high-resolution mass spectrometry.
    J Mol Biol. 2003 Jan 24;325(4):759-72 PMID: 12507478
  80. A structurally disordered region at the C terminus of capsid plays essential roles in multimerization and membrane binding of the gag protein of human immunodeficiency virus type 1.
    J Virol. 2003 Feb;77(3):1772-83 PMID: 12525611
  81. Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase.
    J Virol. 1981 Apr;38(1):239-48 PMID: 6165830
  82. Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins.
    Virology. 1987 Jan;156(1):171-6 PMID: 3643678
  83. High-efficiency transformation of mammalian cells by plasmid DNA.
    Mol Cell Biol. 1987 Aug;7(8):2745-52 PMID: 3670292
  84. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1.
    Proc Natl Acad Sci U S A. 1989 Aug;86(15):5781-5 PMID: 2788277
  85. Immunologic and proteolytic analysis of HIV-1 reverse transcriptase structure.
    Virology. 1990 Apr;175(2):456-64 PMID: 1691562
  86. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release.
    Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3195-9 PMID: 2014240
  87. Genetic analysis of the major homology region of the Rous sarcoma virus Gag protein.
    J Virol. 1995 Jul;69(7):4213-27 PMID: 7769681
  88. Characterization of deletion mutations in the capsid region of human immunodeficiency virus type 1 that affect particle formation and Gag-Pol precursor incorporation.
    J Virol. 1995 Oct;69(10):6106-14 PMID: 7666514
  89. Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1.
    J Virol. 1995 Oct;69(10):6487-97 PMID: 7666550
  90. Crystal structure of SIV matrix antigen and implications for virus assembly.
    Nature. 1995 Dec 14;378(6558):743-7 PMID: 7501025
  91. Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A.
    J Virol. 1996 Aug;70(8):5170-6 PMID: 8764025
  92. Crystal structure of dimeric HIV-1 capsid protein.
    Nat Struct Biol. 1996 Sep;3(9):763-70 PMID: 8784350
  93. Amino acid substitutions in the CA protein of Moloney murine leukemia virus that block early events in infection.
    Virology. 1996 Aug 15;222(2):339-51 PMID: 8806518
  94. Ultrastructure and morphogenesis of human immunodeficiency virus.
    J Electron Microsc (Tokyo). 1996 Aug;45(4):247-57 PMID: 8888583
  95. Differential membrane binding of the human immunodeficiency virus type 1 matrix protein.
    J Virol. 1996 Dec;70(12):8540-8 PMID: 8970978
  96. The role of Gag in human immunodeficiency virus type 1 virion morphogenesis and early steps of the viral life cycle.
    J Virol. 1996 Dec;70(12):8645-52 PMID: 8970990
  97. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid.
    Cell. 1996 Dec 27;87(7):1285-94 PMID: 8980234
  98. Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficiency virus type-1 preparations.
    Virology. 1997 Mar 31;230(1):125-33 PMID: 9126268
  99. Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations.
    Virology. 1997 Mar 31;230(1):134-44 PMID: 9126269
  100. The Nef protein of human immunodeficiency virus type 1 enhances serine phosphorylation of the viral matrix.
    J Virol. 1997 Jun;71(6):4372-7 PMID: 9151826
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2003-05-00
Pages
5439-50
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC153941
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]